The Sloan Kettering Institute (SKI) is seeking a leader for the Single Cell Research Initiative (SCRI), a flagship entity of the Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (GMTEC). SCRI is a single-cell innovation center founded with the mission of providing MSK researchers with access to state-of-the-art single-cell technologies. These approaches are transforming biomedical research by generating transcriptomic, epigenetic and protein marker profiles of individual cells and cell populations within complex tissues. Since its founding, SCRI has helped to further research efforts across MSK by collaborating with dozens of basic, translational and clinical labs, including the study of human tumor microenvironments, response to therapy and animal models of development and disease.
The SCRI Head will identify emerging high-impact single-cell technologies and adapt them to the needs of scientists at MSK, in addition to developing novel technologies. This individual will oversee the diverse range of projects at SCRI and will be responsible for providing support and scientific guidance to researchers. The position provides the option of applying for independent grants and pursuing these research opportunities in addition to SCRI responsibilities. The SCRI Head manages a team of dedicated wet-lab researchers and technicians; he or she serves as the point of contact for academic groups; provides consultation for experimental design and, protocol optimization; oversees data production; and supports publications and grant applications. Other responsibilities include budget planning and oversight, as well as coordination and reporting of program-specific grants, with some administrative assistance . This position is a non-tenure track laboratory faculty position within the Computational and Systems Biology Program of SKI at MSK, with support from department chair and GMTEC Scientific Director Dana Pe’er, a pioneer and established leader in single-cell data analysis. .
SKI offers a highly interactive basic, translational and clinical cancer-focused research environment (www.ski.edu), situated in a multi-institutional academic community that features routine interactions with investigators at Weill Cornell Medical College and the Rockefeller University. The research community at MSK is distinguished by top-tier clinical research, with many exciting opportunities enabled by unparalleled access to samples from one of the highest volumes of cancer patients in the U.S.; a robust research framework for human clinical samples; a range of powerful animal, cell culture and organoid models; deeply intertwined clinical and research staff with a culture of close collaboration; and a large diversity of clinical trials and research initiatives. SCRI is positioned to empower meaningful progress in fighting cancer and other diseases, and a number of its efforts have already led to clinical trials for new treatment modalities.
To qualify, candidates must have a Ph.D. in biochemistry, genomics or a related field as well as at least 2 years of relevant post-degree experience that includes proven skills in all aspects of single-cell research. The successful applicant should be talented and driven, and this individual should command a broad skill set with technical depth in biochemistry, molecular biology, genetic engineering and technology -development. Previous experience in scientific communication and managing a multi-user research environment, particularly related to single-cell technology, would be considered an advantage. The successful applicant should demonstrate the ability to maintain SCRI on the cutting edge. Strong communication and interpersonal skills are also required.
Interested candidates should send a cover letter, CV and a list of three references to Benjamin Hegel firstname.lastname@example.org